Global Vertigo Drugs Market to Surge through
Dublin, Feb. 01, 2024 (GLOBE NEWSWIRE) -- The
Source: globenewswire.com
📰 Otonomy Inc News
Otonomy Inc News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Otonomy Inc. Real-time updates on events, politics, business and more.
Vertigo Drugs Market Research Report 2023 - Global Industry Size, Share, Trends, Opportunity, and Forecasts, 2018-2028F
/PRNewswire/ -- The "Vertigo Drugs Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028F" report has been added to...
Source: prnewswire.com
Global Ear Infection Treatment Market 2023-2028:
Dublin, Sept. 28, 2023 (GLOBE NEWSWIRE) -- The
United States Cipla Ltd Olympus Corporation World Health Organization American Diagnostic Corporation Otonomy Inc
Source: globenewswire.com
Vertigo Drugs Market to grow by USD 551.42 million from 2022-2027, North America to account for 38% of market growth
/PRNewswire/ -- The vertigo drugs market size is expected to grow by USD 551.42 million from 2022 to 2027. In addition, the momentum of the market will...
Source: prnewswire.com
Global Hearing Loss Disease Treatment Market Report 2023: Rising Prevalence of Hearing Loss Drives Growth
/PRNewswire/ -- The "Hearing Loss Disease Treatment Market Share, Size, Trends, Industry Analysis Report, By Product , By Disease Type, By End-User, By Region,...
Source: prnewswire.com
Otonomy (NASDAQ:OTIC) Earns Hold Rating from Analysts at StockNews.com
StockNews.com started coverage on shares of Otonomy (NASDAQ:OTIC – Get Rating) in a report published on Tuesday morning. The brokerage issued a hold rating on the biopharmaceutical company’s stock. Otonomy Stock Performance Shares of Otonomy stock opened at $0.01 on Tuesday. Otonomy has a 12-month low of $0.01 and a 12-month high of $2.54. The […]
Source: theenterpriseleader.com
Otonomy (NASDAQ:OTIC) Research Coverage Started at StockNews.com
StockNews.com started coverage on shares of Otonomy (NASDAQ:OTIC – Get Rating) in a research note published on Tuesday morning. The firm issued a hold rating on the biopharmaceutical company’s stock. Otonomy Price Performance NASDAQ:OTIC opened at $0.01 on Tuesday. Otonomy has a one year low of $0.01 and a one year high of $2.54. The […]
Source: modernreaders.com
StockNews.com Begins Coverage on Otonomy (NASDAQ:OTIC)
StockNews.com initiated coverage on shares of Otonomy (NASDAQ:OTIC – Get Rating) in a research report released on Monday morning. The firm issued a hold rating on the biopharmaceutical company’s stock. Otonomy Stock Performance Shares of OTIC stock opened at $0.01 on Monday. Otonomy has a 12 month low of $0.01 and a 12 month high […]
Source: kopsource.com
Otonomy (NASDAQ:OTIC) Now Covered by Analysts at StockNews.com
StockNews.com initiated coverage on shares of Otonomy (NASDAQ:OTIC – Get Rating) in a report issued on Monday morning. The firm issued a hold rating on the biopharmaceutical company’s stock. Otonomy Stock Performance Otonomy stock opened at $0.01 on Monday. Otonomy has a 52-week low of $0.01 and a 52-week high of $2.54. The firm has […]
Silverarc Capital Management Dimensional Fund Advisors Otonomy Company Profile Otonomy Inc Get Rating Fund Advisors
Source: modernreaders.com
Head to Head Comparison: Mainz Biomed (NASDAQ:MYNZ) vs. Otonomy (NASDAQ:OTIC)
Mainz Biomed (NASDAQ:MYNZ – Get Rating) and Otonomy (NASDAQ:OTIC – Get Rating) are both small-cap medical companies, but which is the better business? We will compare the two companies based on the strength of their valuation, earnings, institutional ownership, profitability, dividends, risk and analyst recommendations. Institutional and Insider Ownership 0.1% of Mainz Biomed shares are […]
Source: theenterpriseleader.com